|
1
|
Gooi Z, Fakhry C, Goldenberg D, Richmon J
and Kiess AP; Education Committee of the American Head and Neck
Society (AHNS), : AHNS Series: Do you know your guidelines?
Principles of radiation therapy for head and neck cancer: A review
of the National Comprehensive Cancer Network guidelines. Head Neck.
38:987–992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lewis CM, Hessel AC, Roberts DB, Guo YZ,
Holsinger FC, Ginsberg LE, El-Naggar AK and Weber RS: Prereferral
head and neck cancer treatment: Compliance with national
comprehensive cancer network treatment guidelines. Arch Otolaryngol
Head Neck Surg. 136:1205–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong YM, Gan WG and Xu ZH: Significance of
the expression of integrin β1, VEGF and MVD in hypopharyngeal
squamous cell carcinoma. Genet Mol Res. 13:6455–6465. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zvrko E, Mikic A and Vuckovic L:
Clinicopathologic significance of CD105-assessed microvessel
density in glottic laryngeal squamous cell carcinoma. Auris Nasus
Larynx. 37:77–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chien CY, Su CY, Hwang CF, Chuang HC,
Hsiao YC, Wu SL and Huang CC: Clinicopathologic significance of
CD105 expression in squamous cell carcinoma of the hypopharynx.
Head Neck. 28:441–446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ge N, Lin HX, Xiao XS, Guo L, Xu HM, Wang
X, Jin T, Cai XY, Liang Y, Hu WH and Kang T: Prognostic
significance of Oct4 and Sox2 expression in hypopharyngeal squamous
cell carcinoma. J Transl Med. 8:942010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kotwall C, Sako K, Razack MS, Rao U,
Bakamjian V and Shedd DP: Metastatic patterns in squamous cell
cancer of the head and neck. Am J Surg. 154:439–442. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Milisavljevic D, Stankovic M, Zivic M,
Popovic M and Radovanović Z: Factors affecting results of treatment
of Hypopharyngeal Carcinoma. Hippokratia. 13:154–160.
2009.PubMed/NCBI
|
|
9
|
Chu PY, Wang LW and Chang SY: Surgical
treatment of squamous cell carcinoma of the hypopharynx: Analysis
of treatment results, failure patterns, and prognostic factors. J
Laryngol Otol. 118:443–449. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chu PY and Chang SY: Reconstruction of the
hypopharynx after surgical treatment of squamous cell carcinoma. J
Chin Med Assoc. 72:351–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Black DL: Protein diversity from
alternative splicing: A challenge for bioinformatics and
post-genome biology. Cell. 103:367–370. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng S: IRAS: High-throughput
identification of novel alternative splicing regulators. Methods
Enzymol. 572:269–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hastings ML and Krainer AR: Functions of
SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.
RNA. 7:471–482. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Manley JL and Tacke R: SR proteins and
splicing control. Genes Dev. 10:1569–1579. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mayeda A, Munroe SH, Cáceres JF and
Krainer AR: Function of conserved domains of hnRNP A1 and other
hnRNP A/B proteins. EMBO J. 13:5483–5495. 1994.PubMed/NCBI
|
|
16
|
Neubauer G, King A, Rappsilber J, Calvio
C, Watson M, Ajuh P, Sleeman J, Lamond A and Mann M: Mass
spectrometry and EST-database searching allows characterization of
the multi-protein spliceosome complex. Nat Genet. 20:46–50. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lallena MJ, Chalmers KJ, Llamazares S,
Lamond AI and Valcárcel J: Splicing regulation at the second
catalytic step by Sex-lethal involves 3′ splice site recognition by
SPF45. Cell. 109:285–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Silverman EJ, Maeda A, Wei J, Smith P,
Beggs JD and Lin RJ: Interaction between a G-patch protein and a
spliceosomal DEXD/H-box ATPase that is critical for splicing. Mol
Cell Biol. 24:10101–10110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Svec M, Bauerová H, Pichová I, Konvalinka
J and Strísovský K: Proteinases of betaretroviruses bind
single-stranded nucleic acids through a novel interaction module,
the G-patch. FEBS lett. 576:271–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaouki AS and Salz HK: Drosophila SPF45:
A bifunctional protein with roles in both splicing and DNA repair.
PLoS Genet. 2:e1782006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sampath J, Long PR, Shepard RL, Xia X,
Devanarayan V, Sandusky GE, Perry WL III, Dantzig AH, Williamson M,
Rolfe M and Moore RE: Human SPF45, a splicing factor, has limited
expression in normal tissues, is overexpressed in many tumors, and
can confer a multidrug-resistant phenotype to cells. Am J Pathol.
163:1781–1790. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakoda T, Kasahara N, Hamamori Y and Kedes
L: A high-titer lentiviral production system mediates efficient
transduction of differentiated cells including beating cardiac
myocytes. J Mol Cell Cardiol. 31:2037–2047. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perry WL III, Shepard RL, Sampath J, Yaden
B, Chin WW, Iversen PW, Jin S, Lesoon A, O'Brien KA, Peek VL, et
al: Human splicing factor SPF45 (RBM17) confers broad multidrug
resistance to anticancer drugs when overexpressed-a phenotype
partially reversed by selective estrogen receptor modulators.
Cancer Res. 65:6593–6600. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Ayoubi AM, Zheng H, Liu Y, Bai T and
Eblen ST: Mitogen-activated protein kinase phosphorylation of
splicing factor 45 (SPF45) regulates SPF45 alternative splicing
site utilization, proliferation, and cell adhesion. Mol Cell Biol.
32:2880–2893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Conaway L, Rutherford Bethard J,
Al-Ayoubi AM, Thompson Bradley A, Zheng H, Weed SA and Eblen ST:
Phosphorylation of the alternative mRNA splicing factor 45 (SPF45)
by Clk1 regulates its splice site utilization, cell migration and
invasion. Nucleic Acids Res. 41:4949–4962. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuntz K and O'Connell MJ: The G(2) DNA
damage checkpoint: Could this ancient regulator be the Achilles
heel of cancer? Cancer Biol Ther. 8:1433–1439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bucher N and Britten CD: G2 checkpoint
abrogation and checkpoint kinase-1 targeting in the treatment of
cancer. Br J Cancer. 98:523–528. 2008. View Article : Google Scholar : PubMed/NCBI
|
